H1-MR-spectroscopy of cerebellum in adult attention deficit/hyperactivity disorder

https://doi.org/10.1016/j.jpsychires.2010.02.016Get rights and content

Abstract

Introduction

Neurobiological research has implicated the cerebellum as one possible site of neurophysiological dysfunction in ADHD. Latest theoretical conceptualizations of the cerebellum as core site of the brain to model motor as well as cognitive behavior puts further weight to the assumption that it might play a key role in ADHD pathophysiology.

Methods

30 medication free adult ADHD patients and 30 group matched (gender, age and education) healthy controls were investigated using the method of chemical shift imaging (CSI) of the cerebellum. The vermis, left and right cerebellar hemispheres were processed separately.

Results

We found significantly increased glutamate-glutamine (Glx) to creatine (Cre) ratios in the left cerebellar hemisphere. No other differences in measured metabolite concentrations were observed.

Discussion

To our knowledge this is the first evidence for neurochemical alterations in cerebellar neurochemistry in adult ADHD. They relate well to recent hypotheses that the cerebellum might control mental activities by internal models.

Introduction

Attention-deficit/hyperactivity disorder (ADHD) is a serious mental problem which begins in childhood and may persist into adult life in a substantial subgroup of patients (Biederman and Faraone, 2005). The prevalence of ADHD in adults is estimated by nearly 4% (Kessler et al., 2006). Since the level of hyperactivity tends to decline from childhood to adulthood the ADHD symptoms in adults are less obvious for the observer (Biederman et al., 2000) but still cause significant impairments in occupational performance and social life. Adult ADHD is associated with low self esteem, higher rates of motor vehicle accidents, higher risks of substance abuse and other co-occurring psychiatric disorders compared to common population (Philipsen et al., 2009, Spencer et al., 2002). The high prevalence, the global impairment and the chronicity of this disorder led the Center for Disease Control and Prevention to identify ADHD as a serious public health problem (Spencer et al., 2002).

The DSM-IV distinguishes three subtypes of attention deficit disorder: the predominantly inattentive subtype (ADD) which is characterized by predominant impairments in attention and concentration, forgetfulness and disorganized behavior, the predominantly hyperactive-impulsive subtype (ADHD) which in contrast is characterized by a combination of hyperactivity and impulsivity, and the combined subtype with symptoms of both subtypes (Biederman et al., 2000, Hesslinger et al., 2001).

The precise etiology of ADHD is not fully understood. Most current theories focus on dysfunction in the prefrontal brain as well as in striatal and thalamic structures (i.e. fronto-striato-thalamo-frontal circuits) (Ashtari et al., 2005, Castellanos et al., 2002, Hynd et al., 1990, Semrud-Clikeman et al., 2000).

However, in structural imaging research cerebellar abnormalities are among the most consistently reported findings in ADHD. Many volumetric studies reported reduced cerebellar volumes and developmental alterations of cerebellum in ADHD children (Berquin et al., 1998, Castellanos et al., 2001, Castellanos et al., 2002, Mackie et al., 2007, Mulder et al., 2008).

Because of its dense connection to the prefrontal cortex and basal ganglia, the cerebellum is thought to play an important role in cognition including verbal working memory, implicit learning, temporal information processing as well as shift in attention and emotional regulation (Ito, 2008, Ivry et al., 2002, Schmahmann and Sherman, 1998, Schmahmann, 2004, Vaidya and Stollstorff, 2008).

Neurochemically, dopamine plays the central role in most pathogenetic models of ADHD (Biederman and Faraone, 2005). This assumption is based on the observation of the good efficacy of the dopaminergic and adrenergic substance methylphenidate in treating ADHD symptoms but also based on clinical and neuroimaging findings (Dougherty et al., 1999, Krause et al., 2000). In a previous study we were able to show increased glutamate signals in the anterior cingulate cortex (ACC) in adult ADHD patients (Perlov et al., 2007). The model of dopaminergic/glutamatergic interaction was developed by Carlsson and coworkers for schizophrenia but seems to be applicable also to ADHD (Perlov et al., 2008a)). To our knowledge the cerebellum of ADHD patients has not been yet investigated using the Magnet-Resonance-Spectroscopy (MRS).

The current study investigates the glutamatergic metabolism in cerebellum of adult ADHD patients using the method of H1-MRS. MRS is a unique non-invasive MRI method to detect metabolites in vivo. Basically MRS uses the different spin-echo signal of the protons differently connected in molecules. Due to the methodological reasons only some of several known metabolites can be detected using the different methods of MRS. The most widely established detectable metabolites in the human brain are: N-acetylaspartate (NAA) – a marker of the cell integrity; choline compounds (Cho) – an important part of cell membranes and to a lesser degree of the energy metabolism; creatine (Cre) – a marker of cell metabolism especially in muscle tissue (due to the fact that it is often regarded as a rahter constant metabolite it is generally used as a denominator for building metabolite ratios if absolute quantification is not possible); myo-inositol (mI) – an important second messenger and glutamate-glutamine (Glx) – the most important excitatory amino acid in the human brain.

Based on our earlier findings in the anterior cingulate cortex (ACC) we hypothesized to observe alterations in glutamate-glutamine signals in adult ADHD patients. In order to maximize the region of interest including the vermis and both hemispheres of the cerebellum we used the method of chemical shift imaging (CSI).

Section snippets

Methods and materials

Approval from the local ethics committee was obtained before onset of the study. The data presented here are part of a larger and ongoing project at the University Hospital of Freiburg in which we are attempting to define the cross-sectional and longitudinal neuroanatomy and neurochemistry in adult ADHD patients [Freiburg ADHD Imaging Study in Adults (FAISA)]. Previous papers from this project are already published (Perlov et al., 2007, Perlov et al., 2008b)

Comparison of study groups

We analyzed data of 30 adult patients with ADHD and 30 group-matched healthy control subjects. The two groups did not differ significantly with regard to age (control group mean 29.9 ± 7.6, ADHD group mean 32.1 ± 10.1; T = 0.94, df = 58, p = 0.35), gender (ADHD/controls: male = 18/15, female = 12/15, Chi-square = 0.61, df = 1, p = 0.44) and level of education measured in years of school education (control group mean 11.9 ± 1.2, ADHD group mean 12.1 ± 1.4; T = 0.51, df = 58, p = 0.61). In ADHD

Discussion

This is the first study in patients with ADHD that specifically investigated the cerebellar neurochemistry employing the method of MRS. We found evidence for disturbed glutamatergic neurotransmission in the left cerebellum hemisphere in terms of an increased Glx to creatine ratio.

There are limitations to this study which we want to mention before discussing the relevance of these findings.

Role of funding source

The finding for this work were provided through the scientific budget of the Department of Psychiatry and Psychotherapy the University Hospital of Freiburg. No other funding was acquired.

Contributions

Evgeniy Perlov, MD. Essentially contributed to data acquisition and analysis and to drafting and finalising the manuscript.

Ludger Tebarzt van Elst, Prof. MD. Conceived the study and designed it, contributed to the statistical analyses and interpretation of findings. He contributed substantially to the writing of the manuscript in all sections.

Martin Buechert, PhD. Supported the MR-data acquisition protocol and methodical development. He contributed substantially to the writing of the “Methods”

Conflict of interests

All authors stated no conflict of interests concerning this work.

Acknowledgements

There are no acknowledgements to this manuscript.

References (55)

  • E. Perlov et al.

    Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder – a magnet resonance spectroscopy study

    Journal of Psychiatric Research

    (2007)
  • L.J. Seidman et al.

    Structural brain imaging of attention-deficit/hyperactivity disorder

    Biological Psychiatry

    (2005)
  • M. Semrud-Clikeman et al.

    Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity

    Journal of American Academy of Child and Adolescent Psychiatry

    (2000)
  • L. Tebartz van Elst et al.

    Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study

    Biological Psychiatry

    (2005)
  • E.M. Valera et al.

    Functional neuroanatomy of working memory in adults with attention-deficit/hyperactivity disorder

    Biological Psychiatry

    (2005)
  • G. Bach-Y-Rita et al.

    Episodic dyscontrol: a study of 130 violent patients

    The American Journal of Psychiatry

    (1971)
  • P.C. Berquin et al.

    Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study

    Neurology

    (1998)
  • J. Biederman et al.

    Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type

    The American Journal of Psychiatry

    (2000)
  • S.J. Blakemore et al.

    The perception of self-produced sensory stimuli in patients with auditory hallucinations and passivity experiences: evidence for a breakdown in self-monitoring

    Psychological Medicine

    (2000)
  • A. Carlsson et al.

    A glutamatergic deficiency model of schizophrenia

    The British Journal of Psychiatry. Supplement

    (1999)
  • N. Carrey et al.

    Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series

    Journal of Child and Adolescent Psychopharmacology

    (2002)
  • N.J. Carrey et al.

    Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder

    Journal of Child and Adolescent Psychopharmacology

    (2007)
  • F.X. Castellanos et al.

    Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder

    Archives of General Psychiatry

    (2001)
  • F.X. Castellanos et al.

    Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder

    Archives of General Psychiatry

    (1996)
  • F.X. Castellanos et al.

    Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder

    JAMA

    (2002)
  • S.L. Collinson et al.

    Frontal executive impairment associated with paraneoplastic cerebellar degeneration: a case study

    Neurocase

    (2006)
  • H. Courvoisie et al.

    Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings

    Journal of Neuropsychiatry and Clinical Neurosciences

    (2004)
  • Cited by (38)

    • Methylphenidate alters monoaminergic and metabolic pathways in the cerebellum of adolescent rats

      2018, European Neuropsychopharmacology
      Citation Excerpt :

      Amino acid neurotransmitters, including glutamate and its precursor glutamine, together with GABA, have been implicated in the pathophysiology of ADHD (Bollmann et al., 2015; Moore et al., 2006; Perlov et al., 2010, 2007). In particular, cerebellar glutamine and glutamate are reported to be abnormally high in ADHD patients when compared to matched controls (Perlov et al., 2010). In the present study, acute MPH (5.0 mg/kg) decreased levels of metabolites associated with excitatory amino acid neurotransmission, i.e. glutamate and its precursor glutamine, while it was found to increase those of the inhibitory amino acids GABA and glycine (Figure 3).

    View all citing articles on Scopus
    View full text